Inflammatory bowel disease: clinical aspects and established and evolving therapies, The Lancet, vol.369, issue.9573, pp.1641-57, 2007. ,
DOI : 10.1016/S0140-6736(07)60751-X
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences, Gastroenterology, vol.126, issue.6, pp.1504-1521, 2004. ,
DOI : 10.1053/j.gastro.2004.01.063
The genetics and immunopathogenesis of inflammatory bowel disease, Nature Reviews Immunology, vol.316, issue.6, pp.458-66, 2008. ,
DOI : 10.1038/nri2340
Dysbiosis as a prerequisite for IBD, Gut, vol.53, pp.1057-1062, 2004. ,
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proc Natl Acad Sci U S A, vol.105, pp.16731-16737, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00652961
Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease, Journal of Molecular Medicine, vol.99, issue.Pt 3, pp.1055-66, 2006. ,
DOI : 10.1007/s00109-006-0100-2
Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer, Oncology Reports, vol.11, pp.951-957, 2004. ,
DOI : 10.3892/or.11.5.951
Defensins and inflammation: The role of defensins in inflammatory bowel disease, Journal of Gastroenterology and Hepatology, vol.56, issue.2, pp.202-210, 2009. ,
DOI : 10.1111/j.1440-1746.2008.05772.x
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease, The Journal of Experimental Medicine, vol.35, issue.9, pp.1883-97, 2009. ,
DOI : 10.1038/nature06005
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737162
Inflammatory bowel disease: cause and immunobiology, The Lancet, vol.369, issue.9573, pp.1627-1667, 2007. ,
DOI : 10.1016/S0140-6736(07)60750-8
Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases, Gastroenterology, vol.129, issue.1, pp.50-65, 2005. ,
DOI : 10.1053/j.gastro.2005.05.013
Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease, Infection and Immunity, vol.68, issue.12, pp.7010-7017, 2000. ,
DOI : 10.1128/IAI.68.12.7010-7017.2000
Nod2 Mutation in Crohn's Disease Potentiates NF-??B Activity and IL-1?? Processing, Science, vol.307, issue.5710, pp.734-742, 2005. ,
DOI : 10.1126/science.1103685
NOD2 is a negative regulator of Toll-like receptor 2???mediated T helper type 1 responses, Nature Immunology, vol.52, issue.8, pp.800-808, 2004. ,
DOI : 10.1016/S0006-291X(02)02807-3
Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2: IMPLICATIONS FOR CROHN'S DISEASE, Journal of Biological Chemistry, vol.278, issue.8, pp.5509-5521, 2003. ,
DOI : 10.1074/jbc.C200673200
The Th1 immune pathway as a therapeutic target in Crohn's disease, Curr Opin Investig Drugs, vol.4, pp.1279-86, 2003. ,
Defects in mucosal immunity leading to ulcerative colitis, Immunological Reviews, vol.95, issue.1, pp.296-305, 2005. ,
DOI : 10.1016/S0016-5085(03)00271-3
Increased expression of interleukin 17 in inflammatory bowel disease, Gut, vol.52, issue.1, pp.65-70, 2003. ,
DOI : 10.1136/gut.52.1.65
Les cellules Th17, m??decine/sciences, vol.24, issue.11, pp.972-978, 2008. ,
DOI : 10.1051/medsci/20082411972
, un nouveau g??ne de susceptibilit?? dans les maladies inflammatoires chroniques intestinales, m??decine/sciences, vol.23, issue.3, pp.250-252, 2007. ,
DOI : 10.1051/medsci/2007233250
Interleukin-17 as an Effector Molecule of Innate and Acquired Immunity against Infections, Microbiology and Immunology, vol.109, issue.12, pp.1139-1186, 2007. ,
DOI : 10.1111/j.1348-0421.2007.tb04008.x
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease, Nature Eur J Pharmacol Gut, vol.44158552, pp.235-8361, 2003. ,
Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease, Inflammatory Bowel Diseases, vol.14, issue.7, pp.1000-1011, 2008. ,
DOI : 10.1002/ibd.20480
Role of angiogenesis in inflammatory bowel disease, Inflammatory Bowel Diseases, vol.12, issue.6, pp.515-538, 2006. ,
DOI : 10.1097/00054725-200606000-00012
IgG Antibodies Against Common Gut Bacteria Are More Diagnostic for Crohn's Disease Than IgG Against Mannan or Flagellin, The American Journal of Gastroenterology, vol.102, issue.8, pp.386-96, 2008. ,
DOI : 10.1189/jlb.0805484